2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow PAD: new trials by email Literature Review of PAD trials Research Report on PAD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant SeV-hFGF2/dF Injection for PAOD Recombinant SeV-hFGF2/dF Injection - PAOD - Peripheral Arterial Occlusive Disease, PAD | Phase 1 | Unknown | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 12 | 2018-09-05 | 2018-10-25 |
| Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) MultiGeneAngio - PAD, Claudication | Phase 1 / Phase 2 | Unknown | MultiGene Vascular Systems Ltd. | 12 | 2006-10-01 | 2015-03-05 |
Chronic Limb-Threatening Ischemia (1) · Intermittent Claudication (1) · Peripheral Arterial Disease (1) · Peripheral Arterial Occlusive Disease 1 (1) · Peripheral Vascular Diseases (1)
Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Ischemia (1) · Pathologic Processes (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1) · Signs and Symptoms (1)
MultiGene Vascular Systems Ltd. (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)
China (1) · United States (1)